Abstract

BackgroundThe valuable clinical data, specimens, and assay results collected during a primary clinical trial or observational study can enable researchers to answer additional, pressing questions with relatively small investments in new measurements. However, management of such follow-on, “ancillary” studies is complex. It requires coordinating across institutions, sites, repositories, and approval boards, as well as distributing, integrating, and analyzing diverse data types. General-purpose software systems that simplify the management of ancillary studies have not yet been explored in the research literature.MethodsWe have identified requirements for ancillary study management primarily as part of our ongoing work with a number of large research consortia. These organizations include the Center for HIV/AIDS Vaccine Immunology (CHAVI), the Immune Tolerance Network (ITN), the HIV Vaccine Trials Network (HVTN), the U.S. Military HIV Research Program (MHRP), and the Network for Pancreatic Organ Donors with Diabetes (nPOD). We also consulted with researchers at a range of other disease research organizations regarding their workflows and data management strategies. Lastly, to enhance breadth, we reviewed process documents for ancillary study management from other organizations.ResultsBy exploring characteristics of ancillary studies, we identify differentiating requirements and scenarios for ancillary study management systems (ASMSs). Distinguishing characteristics of ancillary studies may include the collection of additional measurements (particularly new analyses of existing specimens); the initiation of studies by investigators unaffiliated with the original study; cross-protocol data pooling and analysis; pre-existing participant consent; and pre-existing data context and provenance. For an ASMS to address these characteristics, it would need to address both operational requirements (e.g., allocating existing specimens) and data management requirements (e.g., securely distributing and integrating primary and ancillary data).ConclusionsThe scenarios and requirements we describe can help guide the development of systems that make conducting ancillary studies easier, less expensive, and less error-prone. Given the relatively consistent characteristics and challenges of ancillary study management, general-purpose ASMSs are likely to be useful to a wide range of organizations. Using the requirements identified in this paper, we are currently developing an open-source, general-purpose ASMS based on LabKey Server (http://www.labkey.org) in collaboration with CHAVI, the ITN and nPOD.

Highlights

  • The valuable clinical data, specimens, and assay results collected during a primary clinical trial or observational study can enable researchers to answer additional, pressing questions with relatively small investments in new measurements

  • Ancillary studies allow researchers to leverage the highvalue data collected as part of a primary clinical trial or observational study, augment this data with additional measurements, and answer questions that were not part of the primary study design [1]

  • We identified requirements for ancillary study management primarily as part of our ongoing work with Center for Human immunodeficiency virus (HIV)/AIDS Vaccine Immunology (CHAVI), Immune Tolerance Network (ITN), Network for Pancreatic Organ Donors with Diabetes (nPOD), HIV Vaccine Trials Network (HVTN), Military HIV Research Program (MHRP), and Statistical Center for HIV/AIDS Research and Prevention (SCHARP)

Read more

Summary

Introduction

The valuable clinical data, specimens, and assay results collected during a primary clinical trial or observational study can enable researchers to answer additional, pressing questions with relatively small investments in new measurements. Management of such follow-on, “ancillary” studies is complex. Ancillary studies allow researchers to leverage the highvalue data collected as part of a primary clinical trial or observational study, augment this data with additional measurements, and answer questions that were not part of the primary study design [1]. For primary studies and trials, clinical trial management systems (CTMSs) are widely used to enhance efficiency, reduce costs, comply with regulations, and speed up data analysis. CTMSs are actively studied and developed by the academic community [20,21,22,23,24]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.